Delek US Director Sells $207,350 in Stock

Shlomo Zohar reduces stake by 26.33% through recent stock sales

Mar. 12, 2026 at 2:18pm

Delek US Holdings, Inc. (NYSE:DK) Director Shlomo Zohar sold 5,000 shares of the company's stock on March 9th at an average price of $41.47 for a total value of $207,350. This sale reduced Zohar's stake in the company by 26.33% to 13,989 shares. Zohar also made additional sales of 22,029 shares on March 5th and 7,343 shares on March 4th, totaling around $1.51 million in recent stock sales.

Why it matters

Insider trading activity can provide insights into a company's performance and future outlook. Zohar's substantial stock sales may signal concerns about Delek US's financial health, despite the company's recent earnings beat and dividend declaration.

The details

In the recent stock transactions, Director Shlomo Zohar sold a total of 34,372 shares of Delek US stock, reducing his overall stake in the company by around 26.33%. The sales were executed at average prices ranging from $41.47 to $44.83 per share, resulting in total proceeds of approximately $1.51 million. Delek US reported better-than-expected Q4 2025 earnings of $0.44 per share, beating estimates of -$0.19 per share. The company also declared a $0.255 quarterly dividend, translating to an annualized yield of 2.4%. However, Delek US still shows negative net margin and return on equity.

  • On March 9, 2026, Zohar sold 5,000 shares at $41.47 per share.
  • On March 5, 2026, Zohar sold 22,029 shares at $44.83 per share.
  • On March 4, 2026, Zohar sold 7,343 shares at $43.00 per share.

The players

Shlomo Zohar

A director of Delek US Holdings, Inc. who has recently sold a significant number of shares in the company.

Delek US Holdings, Inc.

An independent downstream energy company engaged in the refining, logistics, and marketing of petroleum products, headquartered in Brentwood, Tennessee.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee

The takeaway

Zohar's substantial stock sales raise questions about Delek US's financial performance and future outlook, despite the company's recent earnings beat and dividend declaration. Investors should closely monitor the company's financial reports and management's commentary for further insights into the reasons behind these insider transactions.